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Abstract
Increased white matter mean diffusivity and decreased fractional anisotropy (FA) has been observed
in subjects diagnosed with mild cognitive impairment (MCI) and Alzheimer's disease (AD). We
sought to determine whether similar alterations of white matter occur in normal individuals at risk
of AD. Diffusion tensor images were acquired in 42 cognitively normal right-handed women with
both a family history of dementia and at least one apolipoprotein E4 allele. These were compared
with images from 23 normal women without either AD risk factor. Group analyses were performed
using tract-based spatial statistics. Reduced FA was observed in the fronto-occipital and inferior
temporal fasciculi (particularly posteriorly), the splenium of the corpus callosum, subcallosal white
matter and the cingulum bundle. These findings demonstrate that specific white matter pathways are
altered in normal women at increased risk of AD years before the expected onset of cognitive
symptoms.
Keywords
Diffusion tensor; Fractional anisotropy; Magnetic resonance imaging; Alzheimer's disease;
Apolipoprotein E
1. Introduction
There is now strong evidence that significant Alzheimer's neuropathology is present years
before any symptoms of mild cognitive impairment (MCI) or Alzheimer's disease (AD) appear
(Braak and Braak, 1997; Bennett et al., 2006). The underlying theory of this study is that the
first appearance of cognitive symptoms due to AD pathology, e.g., amnestic MCI, represents
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early failure of brain compensatory mechanisms and cerebral reserve, a critical point in the
further evolution of neuronal injury produced by that pathology (Smith, 2007). We assume that
AD neuropathology progresses with time. But even if a treatment could theoretically slow or
arrest MCI/AD, other processes of aging and vascular injury could operate on this substrate of
critical reserve and result in further cognitive decline (Schneider et al., 2007). Therefore,
identifying the brain at risk before MCI is important to the goal of preventing the critical point
from ever being reached, by using AD disease-modifying treatments, combined with treatments
aimed at the comorbid pathologies and enhancement of brain reserve, before symptoms appear.
Several methodologies have been applied, or have potential to be applied, to asymptomatic
persons to assess the brain at AD risk, including cerebrospinal fluid protein patterning, genetic
analysis, resting glucose positron emission tomography, and functional and structural magnetic
resonance imaging. Studies of white matter integrity using magnetic resonance diffusion tensor
imaging have demonstrated alterations in the frontal, temporal and parietal lobes in subjects
with MCI and AD (Medina et al., 2006; Xie et al., 2006; Fellgiebel et al., 2007; Firbank et al.,
2007; Huang et al., 2007; Stahl et al., 2007; Sydykova et al., 2007; Teipel et al., 2007; Zhang
et al., 2007; Ding et al., 2008; Rose et al., 2008; Yasmin et al., 2008). There is pathological
evidence that disruption of white matter in Alzheimer's disease may be an early event (Englund
et al., 1988). In line with this data, there is important recent evidence suggesting that normal
persons at increased risk for late-onset AD by virtue of an apolipoprotein-E4 (APOE4) allele
show reduced fractional anisotropy (FA) in certain brain regions compared to low-risk groups
(Nierenberg et al., 2005; Persson et al., 2006a,b). However, these studies have either explored
only a few regions with ROI analyses, or used automated techniques known to have limitations
related to registration and smoothing (Bookstein, 2001; Smith et al., 2006). In the present study
we applied rigorously validated methods for comparing group fractional anisotropy maps
across the brain's white matter (Smith et al., 2006) between well-characterized normal subjects
who vary in their risk of AD. The main advantages of these methods are improved registration
of white matter, the lack of a need to apply an arbitrary smoothing kernel, and a common
reference framework (mean FA skeleton). In addition, because the method is voxel-based,
arbitrary definitions of region of interest are not required.
2. Methods
2.1. Subjects
All subjects are participants in a University of Kentucky longitudinal imaging study of normal
persons who vary in their risk of AD based on family history of dementia and APOE allele
status (Smith et al., 1999, 2002). Inclusion criteria include generally good health without
memory complaints, stable medication regimen, right handed female between the age of 40
and 90 years, vision correctable to at least 20/50, and knowledge of family history (FH). Family
history was considered positive if one or more first-degree relatives had late-onset progressive
dementia. Only right-handed females were recruited because they are part of a larger
multimodal imaging study that includes functional magnetic resonance imaging during
language-based tasks. Language task-based fMRI is known to demonstrate gender and
handedness activation differences.
Exclusions include current medical evaluation or treatment for acute or worsening complaints
(e.g., unstable asthma), stroke or other cerebral injury, psychoactive medications except stable
doses of serotonin reuptake inhibitors and absence of active depression, significant head injury
(operationally loss of consciousness greater than 5 min), significant psychiatric history,
claustrophobia, metallic implants in the head or neck, pacemakers, major surgery within 3
months, or death of one or both parents before age 65.
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Participants who are selected for scanning based on risk undergo standardized psychometric
testing which includes the Mini Mental State Examination (MMSE), Trails A (TA) and B (TB),
FAS Letter Fluency (LF), Wechsler Adult Intelligence Scale (WAIS) Block Design (Block
Des) and Vocabulary (Vocab), 15-item Boston Naming Test (BNT), Wechsler Memory Scale
(WMS) Logical Memory I (LM Imm) and II (LM Del), Visual Reproduction immediate and
delayed (VR and VR Del), Digit Span (DS), Spatial Span (SS), Selective Reminding Test
Immediate and Delayed (SRT & SRT Del), and Beck depression inventory (Beck).
Abbreviations are given for reference to Table 1B. These tests are given to exclude persons
with cognitive impairment and to document equivalent normal cognitive test performance
between risk groups. All subjects had an APOE allele determination. APOE alleles were
determined using polymerase chain reaction (PCR) amplification followed by enzymatic
digestion and separation of DNA fragments by agarose gel electrophoresis. Informed consent
was obtained from each enrollee under an approved University of Kentucky medical
institutional review board protocol.
Forty-four high risk (both FH dementia and one or more APOE4 alleles) and 27 low risk
(neither FH nor APOE4) participants underwent diffusion tensor magnetic resonance imaging
(DT-MRI) between the years 2006 and 2007. One of each risk group were excluded because
of poor memory performance on cognitive testing (1.5 S.D. below the mean on Logical
Memory II), and an additional one of the high risk and three of the low-risk group were not
analyzed because of poor quality MRI scans. None of the included scans demonstrated small
or large-vessel infarcts. Consequently there were 42 in the high-risk and 23 in the low-risk
group available for DT analysis. Demographic information and testing results are summarized
in Table 1. Psychometric scores that sample general mental ability, processing speed, and
delayed verbal and nonverbal memory are provided in the table.
Demographic and psychometric scores were compared between risk groups. First age and
education were entered as response variables in a standard least-squares analysis with risk
group as the independent variable (Table 1A). Age and education were chosen as the most
likely to variables to affect psychometric test scores. Because all subjects were right-handed
females, gender and handedness were not factors. A standard least-squares model was then
developed for the psychometric test scores, with risk group, age, education and risk by age
interaction as the independent variables versus the following independent variables: MMSE,
Logical Memory immediate and delayed, Block Design, Visual Reproduction immediate and
delayed, Boston naming, Vocabulary, Selective Reminding Test immediate and delayed, Trails
A and B, Letter Fluency, Spatial Span, Digit Symbol, and Beck inventory score (Table 1B).
To test for potential differences between risk groups related to vascular factors or estrogen
replacement that might affect white matter, Chi-Square analysis using Pearson's criterion
without correction for multiple comparisons was performed on the following categorical
variables (Present/Not Present): current smoking, past smoking, current estrogen replacement,
past estrogen replacement, hypercholesterolemia, hypertension and diabetes. There were three
subjects with stable diabetes in the study, one in the low-and two in the high-AD risk group.
None of the p-values in these comparisons was less than p = 0.16, demonstrating that the
frequencies of these factors were the same between risk groups. More detailed data is presented
in a supplementary table on the journal web site (http://www.elsevier.com).
2.2. MRI protocol
Scanning was performed on a Siemens Trio 3T instrument. Whole-brain (40-slice) diffusion
tensor images were acquired with 12 encoding directions with 3 averages each (B0 images
were averaged 6 times; TR = 14600 ms, TE = 96 ms; resolution 1.8 mm × 1.8 mm × 3.0 mm)
using a fluid attenuated inversion recovery (FLAIR) double-refocused spin echo sequence.
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2.3. Image processing and statistics
Voxelwise statistical analysis of the FA data was carried out using TBSS (Tract-Based Spatial
Statistics (Smith et al., 2006)), part of the publicly available image processing software FSL
4.0 (http://www.fmrib.ox.ac.uk/fsl/tbss/index.html). TBSS was used because its algorithms for
alignment of FA images from multiple subjects into a common space have been extensively
tested and validated (Smith et al., 2006). In addition, the technique does not require spatial
smoothing of images, which can produce different results based upon the kernel size (Jones et
al., 2005). All of the processing modules referred to below by their acronym are available for
download at the FSL web site. First, FA images were created by fitting a tensor model to the
raw diffusion data using FSL's Diffusion Toolbox, which consists of a series of tools for low-
level diffusion parameter reconstruction and probabilistic tractography.
In order to minimize the extent of warping required for registration to a common target, a subset
of 25 subjects was used to select a target image for nonlinear registration. Subjects forming
both the whole set and the subset were scanned over the same time interval. The subset was
selected in two steps. First, the brain volumes of all subjects were calculated and rank ordered.
Second, age-volume means within the interquartile range were arranged in chronological order,
and the 25 subjects closest in age to the median were selected. From the 25 subjects, the
optimum target image was found.
The subset subjects' FA images were aligned with every other subset subjects' FA images using
the nonlinear registration toolkit IRTK (Rueckert et al., 1999)
(http://www.doc.ic.ac.uk/~dr/software). The common target FA image for the nonlinear
registration was chosen as the FA image for which the least amount of total nonlinear warping
across all subset subjects was necessary for registration to the same space. The least amount
of warping was determined by registration of each subject to every other subject, and
summarization of each warp field by its mean displacement. The resulting target FA image
was then affine registered to MNI space. A single transformation matrix for each of the 65
subjects, combining the nonlinear registration of the subject's FA image to the target FA image
and the affine registration of the target FA image to MNI space, was then applied. The
individual FA images were resampled at 1 mm × 1 mm × 1 mm isotropic voxels using sinc
interpolation.
Next, a mean FA image from all of the subjects was created and thinned with a FA threshold
of 0.2 to create a mean FA skeleton which represents the centers of all tracts common to the
group. Each subject's aligned FA data was then projected onto this skeleton and the resulting
data analyzed using voxelwise cross-subject statistics. A false discovery rate (FDR) threshold
scaled to an alpha of p = 0.05 was determined via random simulations (using 5000
permutations) to correct for multiple comparisons (implemented as in:
http://www.fmrib.ox.ac.uk/fsl/randomise/fdr.html). The FDR was then applied to all voxel-
based group comparisons. Centered age was used as a covariate in the analysis, because the
risk groups showed an overall difference in age (see Section 3).
3. Results
Demographic and testing characteristics of the study groups are given in Table 1. Because no
correction was made for the 16 multiple comparisons in Table 1B, we chose to conservatively
interpret p between 0.01 and 0.05 as indicating marginal significance, and p less than 0.01 as
significant. Low-AD risk subjects were older than high-risk subjects due to the convenience
nature of the sample. We speculate that normal working-age high-risk younger subjects may
be more motivated to volunteer their time for this study than similarly aged low-risk volunteers
because of personal experience with Alzheimer's disease in family members. In previous
studies using APOE allele status for risk stratification, the average age was approximately 67
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years (Nierenberg et al., 2005;Persson et al., 2006a,b), compared to approximately 58 years
for high-risk subjects in the present study. The time to expected development of MCI or AD
is therefore about 9 years greater in the present study. Education level was not different between
risk groups. The frequencies of past and present hypertension, hypercholesterolemia, smoking
and estrogen replacement were similar between risk groups (Supplemental Table).
Correlation with age was in the expected positive direction for Trails A and B, and in the
negative direction for Block Design, Visual Reproduction Immediate and Delayed, Selective
Reminding Test Delayed, and Spatial Span. Education effects were observed only marginally
on the Beck inventory; the absence of these effects overall is attributed to the similar mean and
narrow range of education in the study subjects (Table 1B). The age × risk interaction was
marginally significant for LM immediate interaction, scores decreased with increasing age in
the low-risk group but not for the high-risk group, whereas VR immediate scores decreased
with increasing age in the high-risk group but not for the low-risk group.
Trails A was the only psychometric test of the 16 performed meeting our threshold p-value of
<0.01 for risk group difference. Trails A is a visuomotor task combining visuospatial and motor
speed components. High-risk subjects were slower on this test than low risk. High-risk subjects
were also slower on Trails B, but not significantly. The difference between Trails B and A is
thought to produce a variable with reduced dependence on motor speed. This B minus A
difference when compared between groups was not significant, suggesting that lower
performance on Trails A in high-AD risk subjects was due to decreased motor speed and not
visuospatial factors (high risk 39.9±3.7 S.E.M., low risk 35.7±5.2 S.E.M. seconds; p = 0.5).
As expected, age was positively correlated with B minus A (p = 0.02). Spatial span was lower
in high-risk subjects but not within our cutoff for group difference (Table 1B). In contrast,
there were no differences between risk groups in general mental ability (MMSE, Vocabulary,
BNT) or in memory measures (LM delayed, or in the more sensitive Selective Reminding Test
delayed).
The Beck Inventory score was slightly higher in high-risk subjects but well below the cutoff
of 13 for mild depression (mean 7.3 in high risk and 3.2 in low risk; p = 0.05). The lower Block
Design score in high-risk subjects, although only marginally significant, appeared interesting
at first because of the association with visuospatial intelligence. However, in a direct
comparison of Block Design scaled score between risk groups adjusted for age and education,
the difference was not significant (high risk 11.4±3.70.4 S.E.M., low risk 12.5±0.5 S.E.M.; p
= 0.08), tempering the potential significance of this finding.
Figs. 1-3 illustrate statistical maps rendered on the common FA target image in Montreal
Neurologic Institute (MNI) spatial coordinates, using the contrast: FA high-AD risk less than
FA low risk. The reverse contrast yielded only a few scattered voxels. Maps are referenced to
a standard human white matter atlas (Mori et al., 2005). The maps demonstrate lower FA in
the high-AD risk subjects in: (a) the inferior longitudinal fasciculus of the temporal lobe
posteriorly (particularly inferior fronto-occipital fasciculus bilaterally) and cingulum bundle
posteriorly on the left (Fig. 1), (b) splenium of the corpus callosum, white matter of the
parahippocampal gyrus (left), and right mid cingulum (Fig. 2), and (c) inferior fronto-occipital
fasciculus/uncinate fasciculus anteriorly (Fig. 3). Decreased white matter FA in these specific
regions is seen in the younger high-AD risk group of subjects compared to the older low-AD
risk subjects, the reverse of the increased FA expected with aging; therefore the difference
cannot be attributed to aging. A listing of the center locations of clusters with ≥50 contiguous
voxels (at least 0.05 cm3 volume) is shown in Table 2. These listings provide a concise summary
of relatively spatially coherent FA decreases from results in the figures, which were corrected
for multiple comparisons at the significance level but did not impose a cluster threshold. Cluster
thresholding refers to comparisons based on spatial extent of FA differences.
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4. Discussion
The most important finding was a clearly delineated and highly selective decrease in FA in the
inferior temporal lobe white matter bilaterally (inferior longitudinal fasciculus/inferior fronto-
occipital fasciculus). This decrease has a strong linear spatial character suggesting involvement
of a specific group of white matter fibers bridging the amygdala/hippocampal head region
anteriorly and the ventral visual association areas posteriorly (Fig. 1).
We also found significant FA decreases in the splenium of the corpus callosum, white matter
of the cingulum, and fronto-occipital fasciculus anteriorly. Downward curvature of the
involved fronto-occipital fasciculus shown in Fig. 3, particularly well seen on the left, is
characteristic of this pathway, which parallels the uncinate fasciculus in part of its course. In
general our findings were more robust in the temporal and frontal regions than in parietal lobes,
and more spatially coherent in the ventral visual association regions, medial temporal lobe,
cingulum and frontal lobe than in the parietal lobe or occipital lobe.
Previous studies using DTI in aging and MCI/AD have used several different acquisition and
analysis strategies. Studies of normal aging have shown consistently decreased FA and related
measures with age, particularly in the frontal white matter with relative sparing of the temporal,
parietal and occipital regions (Pfefferbaum and Sullivan, 2003; Furutani et al., 2005; Charlton
et al., 2006; Persson et al., 2006a,b; Sullivan et al., 2006; Grieve et al., 2007; Kochunov et al.,
2007; Madden et al., 2007; Taylor et al., 2007; Abe et al., 2008; Hsu et al., 2008; Hugenschmidt
et al., 2008). Increases of FA with age have not been reliably observed in any region.
In contrast, only a few studies have reported selective findings in the frontal lobe in MCI or
AD (Choi et al., 2005; Sydykova et al., 2007). The remainder have demonstrated more
consistent overlapping findings of decreased FA in the cingulum bundle (Fellgiebel et al.,
2007; Teipel et al., 2007; Zhang et al., 2007), temporal lobe generally (Xie et al., 2006; Huang
et al., 2007; Stahl et al., 2007), parietal lobe and posterior cingulate (Medina et al., 2006;
Firbank et al., 2007; Huang et al., 2007; Ding et al., 2008; Rose et al., 2008), medial temporal
white matter (Fellgiebel et al., 2007; Huang et al., 2007; Yasmin et al., 2008), inferior temporal
lobe, superior and inferior fronto-occipital fasciculi (Xie et al., 2006; Fellgiebel et al., 2007),
and splenium of the corpus callosum (Stahl et al., 2007). Findings in MCI tend to overlap with
AD, particularly in posterior areas. These studies have differed in that some selected a restricted
target region of a priori interest, e.g., the medial temporal white matter or cingulate bundles
(Zhang et al., 2007; Ding et al., 2008; Yasmin et al., 2008), others picked several general regions
of interest within lobar white matter (Fellgiebel et al., 2004, 2007; Choi et al., 2005; Stahl et
al., 2007), whereas still others used a voxel-based technique (Medina et al., 2006; Rose et al.,
2006, 2008; Xie et al., 2006; Firbank et al., 2007; Huang et al., 2007; Sydykova et al., 2007;
Teipel et al., 2007). For comparison the analysis technique we used in this study is voxel-based,
and therefore unbiased with respect to a specific hypothesis regarding where regional FA
differences might be found.
It is important to make the distinction between studies described above that examine subjects
with symptoms of a clinically diagnosed cognitive disorder, e.g., MCI and AD, and studies of
normal persons without symptoms or deficits on psychometric testing who may later develop
these conditions. There are many fewer investigations like the present one that examine the
latter issue. Brain FA alterations that are associated with the presence of a diagnosed clinical
disorder due to an underlying pathology may be assumed to be different in degree, or perhaps
kind, from alterations that predict later development of those symptoms. But it is currently
unknown whether such findings would predict MCI or AD. This is implied but not
demonstrated in studies of at-risk normal persons. The first step in the validation of the current
Smith et al. Page 6
Neurobiol Aging. Author manuscript; available in PMC 2010 July 1.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
findings is to follow these currently (c. 2008) normal study subjects longitudinally to show
whether the observed FA alterations are predictive of later clinically diagnosed MCI or AD.
The voxel-based studies have not been entirely consistent in localization of FA decreases in
AD, e.g., some find frontal and internal capsule alterations, but the overall pattern across studies
suggests alterations in the white matter of the parahippocampal gyrus, inferior longitudinal
fasciculus, splenium of the corpus callosum, parietal white matter, and cingulum bundle
(Medina et al., 2006; Rose et al., 2006, 2008; Xie et al., 2006; Firbank et al., 2007; Huang et
al., 2007; Sydykova et al., 2007; Teipel et al., 2007).
Of particular relevance, a recent study reported reduced FA in the fornix and left frontal WM
in a young group of mildly impaired (CDR = 0.5) subjects (mean age = 35 years old) at risk
for early onset-AD by virtue of fully penetrant genetic alterations (Ringman et al., 2007). Only
two studies have explored WM integrity differences in cognitively normal subjects at risk for
the more common late-onset form of AD due to possession of an APOE4 allele. Using ROI or
SPM techniques, respectively, these studies observed reduced FA in the left parahippocampal
WM (Nierenberg et al., 2005), or the splenium of the corpus callosum, and left posterior
hippocampus (Persson et al., 2006a,b). Our results show some overlap with findings in these
studies, specifically, the findings of decreased FA in the splenium of the corpus callosum and
inferomedial temporal lobes. The location of the present FA decreases in presymptomatic
carriers of AD overlap with previous FA reductions observed in AD in the inferior fronto-
occipital fasciculi (Xie et al., 2006; Fellgiebel et al., 2007), and cingulum bundle (Fellgiebel
et al., 2007; Teipel et al., 2007; Zhang et al., 2007). The term presymptomatic in this context
is a group characterization and should not be interpreted to mean that each individual subject
should be considered presymtpomatic. These findings therefore suggest that AD-related FA
declines are already present in groups of individuals at high risk for AD, even when they are
thinking, behaving and functioning normally.
The strengths of our study are the confirmation of cognitive normality and test performance
equivalence between risk groups using comprehensive psychometric testing of all participants,
rigorous exclusion of confounding neurologic disease, reduction of FA variance due to gender
and cerebral language representation by exclusive recruitment of right handed women (Hsu et
al., 2008), exclusion of potential confounds due to smoking, hypertension,
hypercholesterolemia and estrogen replacement, a consistent imaging protocol across all
subjects using a 3T MRI instrument, and use of an advanced, validated and regionally unbiased
DTI methodology.
Several cautions should be kept in mind in interpreting our results. Despite equivalent cognitive
performance between risk groups, the low-risk subjects were older than the high-AD risk. We
used age as a regressor in all our analyses, but statistical adjustments are not perfect. Because
FA is known to decrease - not increase - with age, a finding of an FA decrease in the younger
high-risk group is the reverse of expectation on an age basis, so we believe the difference in
age strengthens rather than weakens our findings. Nonetheless, the difference in age between
groups should be noted.
Another more important caveat is in interpretation of results. We can only infer that the
alterations we have observed are related to the risk of AD. The study participants were selected
to differ in no respect other than AD risk, but it is possible the groups differed in some other
unknown but important way for which we could not adjust or control. Furthermore, we do not
know that presence of these white matter alterations is due to underlying AD pathology, a basic
hypothesis of the study, because we have no independent verification of its degree or presence,
e.g., by autopsy or brain biopsy.
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The issue of the functional significance of the FA declines in presymptomatic groups also needs
further investigation. This is a tricky issue because presymptomatic high-risk subjects display
cognitive function that is, by definition, comparable to that of low-risk subjects. However,
there is accumulating evidence that FA is of functional significance in young healthy subjects
(Madden et al., 2004; Tuch et al., 2005; Gold et al., 2007), and that age-related FA declines
contribute to some cognitive performance declines (Madden et al., 2004; Gold et al., 2008).
The view that FA declines are functionally relevant is also in-line with our previous finding of
decreased ventral temporal activation in asymptomatic high-AD risk women in an fMRI
naming task (Smith et al., 1999). The fMRI under-recruitments in this previous study of
subjects were in regions adjacent to the postero-inferior FA alterations observed in the present
study. Although both studies were performed using similar subjects selected by the same
criteria, the specific individuals studied were different.
Finally, like other studies of presymptomatic participants, we cannot yet claim a role for altered
FA in predicting AD because the participants have not been followed long enough to observe
even the earliest symptoms for validation. Longitudinal follow up of the participants described
in this study is in place at our center and should yield relevant results in the future.
In summary this report represents further progress toward the goal of identifying the brain at
risk of AD using DTI. We have identified restricted regions of the inferomedial temporal lobes
bilaterally, and other regions, that demonstrate decreased FA in normal high-AD risk subjects,
that may in future serve as a biomarker for the presence of asymptomatic AD pathology. What
we have observed here are specific regions of decreased FA in high-AD risk subjects. The next
step in validating this work is to follow subjects longitudinally to show whether the observed
changes are truly predictive of MCI or AD, and with what accuracy. Therefore, this method is
promising but needs further study before it could be used for that purpose in trials of preventive
agents in AD.
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Fig. 1.
Map showing inferotemporal regions of decreased FA in normal, high-AD risk subjects. The
anatomic underlay used for illustration is the MNI-space registered target FA image. The
registered average FA skeleton is represented in green. Warmer colors on red-orange scale
indicate higher t-values for FA decrease at each voxel (FAhigh risk <FAlow risk). Arrowheads in
(A) mark the sagittal slice locations on the right (B) and on the left (D). Coronal slice level in
A is indicated by single arrowheads in (C). The lineal patterns of FA decrease indicated by the
arrowheads in (B) and (D) correspond to the inferior longitudinal fasciculus/inferior fronto-
occipital fasciculus (Mori et al., 2005). Double arrowheads in (C) point to the posterior
cingulum bundle on the left. Note that decreased FA adheres only to white matter regions.
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Fig. 2.
Decreased FA in the right mid-cingulum bundle and splenium in normal, high-AD risk subjects.
Display conventions are given in Fig. 1 legend. Top row: Arrowheads in (A) and (B) indicate
the mid-portion of the cingulum on the right demonstrating decreased FA. A magnified view
of the region indicated by a box in the mid-sagittal slice is illustrated in B. Arrows in (A)
denotes symmetric cingulate areas with decreased FA on the left, but this region does not have
the lineal spatial coherence of the right-sided counterpart. Bottom row: Arrowheads in (C) and
(D) mark the region of decreased FA in the splenium of the corpus callosum. Double arrows
in (D) indicate decreased FA in the posterior cingulate bundle on the left.
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Fig. 3.
Map showing anterior regions of decreased FA in normal, high-AD risk subjects. Display
conventions are given in Fig. 1 legend. Arrowheads in A mark the sagittal slice locations on
the right (B) and on the left (D). Coronal slice level in A is indicated by single arrowheads in
(C). The coherent patterns of FA decrease indicated by the arrows in (B) and (D) correspond
to the inferior fronto-occipital fasciculus(Mori et al., 2005). Downward curvature of the FA
decrease region, best seen on the left in (B), is typical of this tract.
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Table 1A
Age and education of study participants
Group N Age, years Education, years
High risk 42 57.7 ± 1.1 15.7 ± 0.4
Low risk 23 68.1** ± 1.5 15.9 ± 0.6
p- Value - <0.0001 0.73
Standard Least Squares analysis using age and education as response variables and risk as regressor (Least square means ± S.E.M.).
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Table 2
Locations of voxels with decreased FA in high-AD risk participants
Location Tract Nearest BA
-27, -77, 2 Inferior fronto-occipital fasciculus L (posterior) 19
25, -78, 2 Inferior fronto-occipital fasciculus R (posterior) 19
-38, -63, -8 Inferior fronto-occipital fasciculus L (posterior) 19, 37
39, -64, -8 Inferior fronto-occipital fasciculus R (posterior) 19, 37
-37, -55, 0 Inferior longitudinal fasciculus L (posterior) 37
36, -59, 5 Inferior longitudinal fasciculus R (posterior) 37
-19, -36, -7 Cingulum bundle L (posterior) 27, 30
7, -8, 32 Cingulum bundle R (mid) 23, 24
-42, -25, -6 Inferior fronto-occipital fasciculus L (posterior) 21
-15, 2, 56 Cortico-pontine tract 6
-24, 23, 8 Inferior fronto-occipital fasciculus L (anterior) -
26, 28, 2 Inferior fronto-occipital fasciculus L (anterior) -
0, -36, 21 Splenium, corpus callosum -
-4, 3, -10 Subcallosal white matter 25
4, 3, -10 Subcallosal white matter 25
Locations are given in Talairach coordinates in the first Column (Talairach and Tournoux, 1988, 1027), the corresponding tract associated with this
anatomic location in the second Column (Mori et al., 2005 #67), and the nearest neighboring Brodmann cortical area (BA) to the location in the third
Column.
Neurobiol Aging. Author manuscript; available in PMC 2010 July 1.
